Extrait

Background and study aims Gestational diabetes mellitus (GDM) is a type of diabetes that affects women during pregnancy. It is common and is associated with serious complications for the mother and baby. While the need for GDM screening is broadly accepted, there is a debate as to what form this should take, with some advocating universal screening of all pregnant women and others selective screening of high-risk subgroups only. The aim of this study is to find out whether screening all pregnant women for GDM in primary care is clinically effective and cost effective. Who can participate? Pregnant women visiting the maternity clinic at Galway University Hospitals (GUH) at 18-20 weeks gestation. What does the study involve? Participants are randomly allocated to either primary care or secondary care screening for GDM. All women are invited for an oral glucose tolerance test (a test for GDM) at 24-28 weeks gestation. In the primary care screening group, women are tested in their local GP clinic. In the secondary care screening group, women are tested in the maternity unit at GUH. All women with GDM are offered consultations with a dietician and a diabetes nurse specialist and are instructed to self-monitor their blood sugar levels over the remainder of their pregnancy. Women who do not respond to lifestyle changes after two weeks are prescribed insulin for the remainder of their pregnancy. Data is collected to examine how well screening works in primary care compared to screening in secondary care. What are the possible benefits and risks of participating? Not provided at time of registration. When is the study starting and how long is it expected to run for? October 2012 to September 2014. Who is funding the study? This study is funded by the Health Research Board (HRB), an Irish government agency. Who is the main contact? Professor Fidelma Dunne [email protected]

Critère d'inclusion

• Gestational diabetes mellitus

Liens

• ictrp
• isrctn